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Abstract
Complete surgical resection of hyperfunctioning parathyriod tissue is essential for the treatment of primary hyperparathyroidism. Dur-
ing recent years, minimally invasive surgery has been successfully applied in neck exploration, because of significant developments of 
guidance by intraoperative scans, the use of quick, intraoperative PTH assay, and also preoperative imaging procedures such as high-
resolution ultrasonography and sestamibi scintigraphy. The results of operations which are performed with minimally invasive techniques 
are comparable to those of conventional surgery, and provide advantages with regard to cosmetic result, length of hospitalisation, and 
reduced post-operative pain. (Endokrynol Pol 2014; 65 (3): 240–249x)
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Streszczenie
Całkowite chirurgiczne usunięcie nadczynnej tkanki gruczołowej jest kluczowe dla leczenia pierwotnej nadczynności przytarczyc. 
Podczas ostatnich lat, techniki chirurgii małoinwazyjnej były z sukcesem wprowadzane do preparowania tkanek szyi. Było to możliwe 
dzięki opracowaniu śródoperacyjnych metod lokalizowania zmienionej tkanki, szybkim testom oznaczającym stężenie PTH w surowiczy, 
jak również doskonaleniu technik obrazowania przedoperacyjnego, takich jak ultrasonografia wysokiej rozdzielczości czy scyntygrafia 
z wykorzystaniem sestamibi. Wyniki operacji z wykorzystaniem technik małoinwazyjnych są porównywalne z wynikami technik kon-
wencjonalnych oraz wiążą się z zaletami, takimi jak skrócony okres hospitalizacji, zmniejszenie bólu pooperacyjnego czy lepszy efekt 
kosmetyczny. (Endokrynol Pol 2014; 65 (3): 240–249)
Słowa kluczowe: pierwotna nadczynność przytarczyc; konwencjonalne preparowanie tkanek szyi; minimalnie inwazyjna parathyroidectomia
Introduction
The first successful surgery of the parathyroid gland was 
performed by Felix Mandel in Vienna in 1925. The patient 
was symptomatic and had severe primary hyperpar-
athyroidism with bone manifestation and calcinosis. The 
operation was performed under local anaesthesia; four 
parathyroid glands were identified, and a single enlarged 
parathyroid was excised. Since that time, the diagnostics 
and management of parathyroidism including surgery 
have been developed, resulting in a satisfactory outcome 
in 95–98% of operated patients [1, 2]. 
Pharmacological treatment of parathyroidism is 
quite costly and offers limited benefits. Parathyroidec-
tomy has superior outcomes and is cost-effective both 
in symptomatic and asymptomatic primary hyperpar-
athyroidism. It is recommended that those patients who 
are able and willing to undergo a surgical procedure 
should have a consultation with an experienced para-
thyroid surgeon [21].
As for surgical options for the treatment of primary 
hyperparathyroidism, there are two basic techniques. 
One is bilateral neck exploration, which is thought to 
be the ‘gold standard’. This demands (as in the case de-
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scribed above) visualisation of all glands; their morphol-
ogy determines the need for resection. The traditional 
neck exploration and excision of abnormal parathyroid 
tissue is effective and associated with low morbidity. 
Patients are usually discharged after a single-night hos-
pital stay and are able to return to their normal activities 
within two weeks after the operation. The cure rates of 
this technique are 90-95%, with a complication rate of 
about 1–3%, which concerns mainly recurrent laryngeal 
nerve injury and temporary hypocalcaemia [2, 3]. 
Despite the success of the traditional surgical ap-
proach to parathyroid disease, an alternative approach 
that minimises the disability associated with surgery is 
always desirable. In recent years, radio-guided [5], en-
doscopic and video–assisted gasless techniques [1] have 
been used to develop a minimally invasive approach to 
surgery for primary hyperparathyroidism in order to limit 
patient discomfort, shorten convalescence, and, most im-
portantly, improve the cosmetic result [3, 4]. In the setting 
of minimally invasive parathyroidectomy, pre-operative 
localisation of abnormal parathyroid tissue is absolutely 
mandatory. The development in imaging is thought to 
be the most important factor which allows this method 
to be performed with successful results. The definition of 
minimally invasive parathyroid surgery can be described 
as the removal of the affected parathyroid gland without 
four-gland visualisation. This is possible because primary 
hyperparathyroidism is caused by a solitary adenoma in 
85–90% of cases. The avoidance of unnecessary explora-
tion of normal parathyroids makes this technique desir-
able. It is further important in the context of avoiding 
making subsequent surgery in the thyroid region more 
difficult and more prone to complications. 
Minimally invasive parathyroidectomy generally is 
classified into three main groups. The first group involves 
a small skin incision in the supraclavicular region with uni-
lateral exploration. This method is sometimes performed 
under local anaesthesia. The second group is endoscopic 
parathyroidectomy performed with CO2 insufflation at 
a pressure of less than 4 mmHg (which is sufficient for 
lifting only the platysma) after inserting trocars through 
the skin of the neck, anterior chest or axilla (the last two 
approaches are also known as remote access endoscopic 
parathyroidectomy) [8]. The third group, gasless endo-
scopic parathyroidectomy, is performed using a small skin 
incision. This method is called ‘video-assisted’ parathy-
roidectomy. The operating field is clearly identified with 
a high-magnification video camera, and the whole field 
can also be visualised from a remote position [5, 6]. Some-
times, complete endoscopic and video-assisted approches 
(video-endoscopic parathyroidectomy), video-assisted 
and open approach (open videoscopically magnified 
parathyroidectomy) are used in combination [19].
These minimally invasive parathyroidectomy tech-
niques are performed with low morbidity and excellent 
cure rates in patients with primary hyperparathyroidism.
Indications and contraindications
The most common causes of hyperparathyroidism can 
be described using the acronym RHINOS [50]:
 — R — Renal insufficiency (secondary and tertiary 
hyperparathyroidism)
 — H — Hyperparathyroidism (solitary and combined 
in MEN1and MEN2a)
 — I — Immobilisation and iatrogenic (overdosage of 
calcium, vitamin D, thiazids)
 — N — Neoplasms (bone metastasis, primary bone 
cancer and paraneoplasmatic syndromes)
 — O — Other endocrinopathies (thyrotoxicosis and 
Addison’s disease)
 — S — Sarcoidosis
Recommendations for parathyroidectomy formu-
lated by the National Institutes of Health Consensus 
Conference on Hyperparathyroidism in 1991 were 
widened in 2002 and 2008 [22] (Table I).
Table. I. Recommendations for parathyroidectomy
Tabela I. Rekomendacje dotyczące wycięcia przytarczyc
Serum calcium (> upper limit of normal) 1.0 mg/dL (0.25 mmol/L)
Urine calcium excretion > 400 mg/day (*not indicated after 2008)
Creatinine clearance Reduced by 30% compared to age-matched control patients (< 60 mL/min *2008)
Bone mineral density T-score < –2.5 at any site and/or previous fracture fragility
Patient who is symptomatic Bone pain of osteitis fibrosa cystica
Significant neuromuscular symptoms
Nephrolithiasis Clinically or detected radiographically
Life-threatening hypercalcaemia: One previous episode
Patient age Under 50 
Surveillance not desirable or suitable
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Most patients with biochemically proven primary 
hyperparathyroidism can undergo minimally invasive 
parathyroidectomy. Contraindications for the mini-
mally invasive technique include [1, 3, 4, 18]: 
 — the presence of multiglandular disease;
 — the presence of multiple endocrine neoplasia, ma-
lignancy [48];
 — the presence of concomitant thyroid disease (rela-
tive);
 — previous neck surgery or irradiation of the neck;
 — nodular goitre;
 — lithium associated primary hyperparathyroidism;
 — failure to localise the adenoma preoperatively;
 — unfavourable surgical anatomy.
Operating techniques
Preoperative localisation of hyperfunctioning 
parathyroid gland
The preoperative localisation studies usually consist of 
high-resolution ultrasonography and sestamibi-99mTC 
subtraction scintigraphy with SPECT (single positron 
emitted computed tomography) imaging [5, 8]. Modern 
ultrasound systems still cannot visualise the normal 
parathyroid glands, whereas enlarged, hyperfunctional 
glands can be identified not only on the basis of their 
size and oval shape, but also because of their charac-
teristic ultrasound features including hypoechogenic-
ity, typical intraglandular blood flow, movability and 
noncompressibility [10]. Compared to ultrasonography, 
sestamibi scanning is more sensitive and specific with a 
comparable degree of accuracy (91% and 92% for each 
method respectively) [3]. Sestamibi accumulates well 
in hyperfunctioning parathyroid nodules quickly after 
intravenous injection, as parathyroid lesions usually get 
a high supply of blood [11]. 
Intra-operative blood sampling, PTH Assay- as 
evidence of biochemical cure during minimally 
invasive parathyroidectomy
Rapid intraoperative PTH assays should be routinely 
employed. Intraoperative serum PTH level quantifi-
cation was first introduced in 1990, but has still not 
been accepted as the gold standard in PHPT (primary 
hyperparathyroidism) surgery. Potentially it can pro-
long the operating time [23], but measurement takes 
only 5–10 minutes [24]. Moreover, double adenomas 
have been reported in 2–15% of patients undergoing 
parathyroidectomy [25] and can be missed in up to 
15% of patients diagnosed with single adenoma by 
sestamibi scan [26, 27]. This can lead to reoperations 
with increased risk of complications, unnecessary 
patient stress, and further potential costs. [24] Intra-
operative PTH monitoring is thought to be a very 
important element of parathyroid surgery, because 
it confirms that all hypersecreting parathyroid tissue 
has been excised, prevents multiglandular disease be-
ing overlooked, and helps to predict post-operative 
eucalcaemia during surgey by providing immediate 
information [19].
Blood samples are analysed using the Quick-
IntraOperative Intact PTH assay (Nicholas Institute 
Diagnostics, San Juan Capistrano, CA, USA). PTH levels 
are measured four times during surgery:
 — prior to surgical manipulation,
 — at time 0, i.e. immediately following adenoma ex-
traction,
 — at 5 minutes after adenoma removal,
 — at 10 minutes after adenoma removal.
A decrease in the level of parathyroid hormone is 
considered significant when it is equivalent to more 
than 50% of the highest pre-excisional value [7, 15]. 
Hormone levels typically decrease to normal range 
(15–50 pg/mL) [9] within 10 minutes after removing the 
abnormal gland (Fig. 1). 
Targeted open parathyroidectomy 
Surgical procedure
Patients are positioned on the operating table in a re-
verse Trendelenburg position with their head hyperex-
tended. The surgeon administers a superficial cervical 
block employing 1% lidocaine with a 1:100,000 solution 
of epinephrine. The surgical procedure is performed 
through a 2-cm to 3-cm incision at the medial border 
of the sternocleidomastoid muscle, precisely over the 
site where the enlarged gland had been located by 
preoperative imaging. With the sternocleidomastoid 
muscle and internal jugular vein retracted laterally, 
and the strap muscles medially, the thyroid gland is 
grasped in Ellis forceps and held in the medioventral 
Figure 1. Exemplary PTH drop monitored by intraoperative 
quick PTH assay
Rycina 1. Przykładowy spadek stężenia parathormonu w badaniu 
śródoperacyjnym
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direction. The parathyroid adenoma is identified, its 
blood supply is ligated, the recurrent laryngeal nerve 
is protected, and the adenoma is removed. The wound 
is closed while awaiting the results of the intraoperative 
PTH assay [2, 10].
Endoscopic parathyriodectomy 
Surgical procedure
In 1996, Gagner et al. first described endoscopic parath-
yroidectomy [12] using gas (CO2) insufflation through 
a cervical approach via a small cervical incision (supra 
clavicular position). This operation was complicated by 
intraoperative hypercarbia and extensive subcutaneous 
emphysema postoperatively (because of high carbon 
dioxide pressure) [6]. Nowadays, there is experimental 
evidence that insufflation in the extraperitoneal cavities 
such as the neck is completely harmless as long as the 
operation is performed under low pressure. Interesting-
ly, a bilateral exploration is possible with this technique 
and it can also be used for total parathyroidectomy in 
the treatment of secondary hyperparathyroidism [5, 12].
Endoscopic parathyroidectomy by an anterior  
chest approach
Under general anaesthesia, the patient is placed in the 
supine position with the neck extended. The anterior 
chest approach involves a 5-mm skin incision in the 
chest (3.0 cm below the inferior border of the clavicule 
on both sides of the chest). The lower layer of the platy-
sma is extracted manually. There are three 5 mm trocar-
sites: one trocar is used to insert an endoscope and two 
additional trocars (inserted under endoscopic guidance: 
one inferior to the sternal notch and the other below 
the ipsilateral clavicle) are used to insert instruments. 
CO2 is sufflated up to 4 mm Hg. In order to expose the 
parathyroid glands, the thyroid is rotated forward with 
the retractor through the opposite side 5-mm trocar. 
The adenoma is dissected with endoscopic scissors or 
a Harmonic Scalpel (Johnson-Johnson Medical, Cincin-
nati, OH, USA) to avoid injuring the recurrent laryngeal 
nerve. The specimen is placed in a finger of a plastic 
glove and extracted through the 5-mm skin incision. 
The other ipsilateral parathyroid gland is also explored 
and it is biopsied (if it appears normal) or dissected 
and removed (if it appears enlarged) [5]. A rapid PTH 
test for intraoperative assessment is performed. The 
topography of the approach is visualised in Figure 2. 
Endoscopic parathyroidectomy by an axillary  
approach
Under general anaesthesia, the patient is placed in 
the supine position with the neck slightly extended 
and with raised arm in order to expose the axilla. 
A 30-mm skin incision is made in the axilla. The lower 
layer of the platysma is extracted through the upper 
layer of the pectoralis major muscle. A 12-mm trocar 
and a 5-mm trocar are inserted through this incision. 
After ensuring the prevention of gas leakage and tro-
car slippage out of the wound, CO2 is sufflated up to 
4 mmHg and a flexible endoscope is inserted through 
the trocar. An additional 5-mm trocar is inserted in-
ferior to the 30-mm skin incision. The thyroid gland 
is exposed by splitting the sternothyroid muscle and 
it is rotated forward to reveal the parathyroid glands. 
The adenoma is dissected with endoscopic scissors 
or a Harmonic Scalpel. As for the other ipsilateral 
parathyroid gland and intra-operative PTH monitor-
ing, the procedure is similar to that described above 
[8]. The topography of this approach is visualised 
in Figure 3. 
Endoscopic parathyroidectomy by a cervical  
approach
This procedure is performed totally endoscopically 
under a steady gas flow. It requires general anaesthe-
sia [19, 20]. Small incisions are made for 3-mm, 5-mm 
and 10-mm trocars. One trocar is used to insert the 
endoscope and two additional ones are used to insert 
the instruments. Dissection is first performed below 
the platysma in order to obtain a good working space. 
Exploration of the parathyroid glands is carried out 
after dissection of the thyroid from the investing fascia 
[12]. Bilateral exploration by this method is possible but 
time-consuming.
Figure 2. Topography of endoscopic parathyroidectomy by 
an anterior chest approach
Rycina 2. Topografia paratyroidektomii endoskopowej z dostępu 
klatkowego przedniego
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Endoscopic parathyroidectomy by a postauricular 
approach 
Spinal needles are used to subcutaneously infiltrate 
the subplatysmal space of the neck and the subcutane-
ous space of the axillary and anterior chest area with 
epinephrine solution (0.1 mL of epinephrine [1:1,000] 
in 200 mL of normal saline). The infiltration provides 
space for flap dissection and prevents bleeding. 
A 12-mm axillary incision is made at the lesion’s side, and 
the subplatysmal and subcutaneous spaces are dissected 
bluntly using a vascular tunneller. After establishing the 
required working space, a 12-mm trocar is inserted and 
the operating space under the flap is insufflated with low-
pressure carbon dioxide (5–6 mm Hg). Another incision 
is made on the contralateral axillary region and a 5-mm 
trocar is inserted. Bilateral postauricular incisions are 
then made and two 5-mm trocars are inserted. The 
midline is estimated by external palpation. A midline 
incision is made between the strap muscles from the 
level of the thyroid cartilage to the suprasternal notch. 
After division of the midline of the strap muscles, the 
parathyroid gland is excised [28]. Bilateral exploration 
by this method is possible but time-consuming. The 
topography of the approach is visualised in Figure 4.
Video-assisted parathyroidectomy
Video-assisted parathyroidectomy is typically per-
formed by a central (Miccoli et al.) or a lateral (Henry 
et al.) approach in the line of the sternocleidomastoid 
muscle [6]. 
Surgical procedure
Video-assisted parathyroidectomy by central  
approach
In order to perform this minimally invasive technique, 
the operating surgeon needs two assistants. The sur-
gical procedure is carried out through a 10–15-mm 
skin incision at the suprasternal notch (so it is easy to 
convert to the open method) [6]. The cervical mid-line 
is opened and complete dissection of the thyroid lobe 
is obtained by blunt dissection with small instruments 
under endoscopic vision (without trocar insertion or gas 
insufflation) using a 30 degree 5-mm endoscope. Small 
conventional retractors maintain the optimal visualisa-
tion of the surgical field by lifting the skin. Needlescopic 
instruments (2–3-mm): suction, dissector, and elevator 
are inserted through the same incision and are used 
for the dissection. If another parathyroid tumour is 
found in the ipsilateral side, this gland is also removed 
[6, 19]. Optical identification of the cervical structures 
is amplified by videoscopic magnification, which also 
allows easy recognition of the recurrent laryngeal nerve 
[12, 13]. After removal of the adenoma, a quick para-
thyroid hormone assay excludes the presence of any 
residual hyperfunctioning parathyroid tissue [14]. Bilat-
eral exploration by this method is easy to perform [12].
Figure 3. Topography of endoscopic parathyroidectomy by an 
axillary approach
Rycina 3. Topografia paratyroidektomii endoskopowej z dostępu 
pachowego
Figure 4. Topography of endoscopic parathyroidectomy by 
a postauricular approach
Rycina 4. Topografia paratyroidektomii endoskopowej z dostępu 
zausznego
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Video-assisted parathyroidectomy by lateral  
approach 
This procedure also requires experienced assistants and 
special equipment. The lateral approach is characterised 
by a 12-mm skin incision on the medial border of the 
sternocleidomastoid muscle on the side of the supposed 
lesion. It combines two approaches: complete endo-
scopic and video-assisted. A 10-mm trocar is inserted 
into the same place as the endoscope (10-mm, zero de-
grees), and insufflation is carried out at 8 mm Hg. Two 
small trocars (3-mm) for the instruments for the dissec-
tion are inserted above and below the first trocar along 
the medial margin of the sternocleidomastoid muscle. 
A quick parathyroid hormone assay can be used with 
this procedure. A bilateral exploration is impossible with 
this method, because of the unique lateralisation [12].
The topography of both video-assisted approaches 
is visualised in Figure 5.
Radio-guided parathyroidectomy
Radio-guided parathyroidectomy was first described 
by Norman and Chheda in the mid-1990s [16]. This 
technique utilises preoperative intravenous injection 
of sestamibi and intraoperative navigation by portable 
gamma cameras and hand-held gamma-ray detectors. 
These modern technologies allow all parathyroid op-
erations to be performed through a small 1 inch (2.5 
cm) incision [12].
Preoperative procedure
Pre-operatively, patients are injected with a low dose of 
sestamibi with or without methylene blue dye, which 
in the past has been shown to localise adenomas [3]. 
Readouts are obtained after 5 mins, 1 h and 2 h follow-
ing the injection. These images are useful for intraopera-
tive nuclear mapping [6, 49]. The radio-guided method 
is also effective for ectopic lesions that are located in 
the deep area of the mediastinum, where direct visual 
observation is difficult. The intra-operative navigation 
by gamma-probe can easily lead the surgeon to ec-
topic locations of hyperfunctioning parathyroid glands. 
A hyperfunctioning parathyroid lesion can be clearly 
detected and easily resected by the radio-guided meth-
od when sestamibi is well retained in the lesion in the 
delayed phase- positive sestamibi scan (in about 85–90% 
of patients). If the activity of the lesions in the delayed 
images is faint, and the retention of sestamibi is thought 
to be poor, (which occurs in about 10-15% of patients), the 
radio-guided technique is not attempted [11, 17].
Surgical procedure
Radio-guided parathyroidectomy is performed us-
ing local anaesthesia with some i.v. sedation, or using 
a very light general anaesthesia called LMA which al-
lows the patients to be out for the procedure, but awake 
enough that they breathe for themselves and wake up 
completely within a minute or two [17]. The opera-
tion is performed with unilateral resection technique 
through a transverse midline or unilateral neck incision, 
typically of 2.5 cm. The radioactivity is measured on 
the parathyroid adenoma and the probe used directs 
the surgeon right to it and guides the excision [3]. The 
average operating time to remove the hyperfunctioning 
parathyroid gland using the radio-guided technique is 
about 25 minutes [17]. Confirmation of removal of all 
the hyperfunctioning tissue can be obtained through 
intra-operative scintigraphy, thereby avoiding addi-
tional costs from quick parathyroid hormone assay or 
frozen section. This technique does not allow bilateral 
exploration [12].
NOTES (Natural orifice translumenal endoscopic 
surgery) 
Transluminal endoscopic interventions via so-called 
‘natural orifices’ allow operating treatment without any 
incision of the skin, but they are still in the experimental 
phase. It is possible to perform thyroid and parathyroid 
surgery via transoral access.
Surgical procedure
Access is accomplished via a 20-mm incision in the lat-
eral floor of the mouth. After identification of the lingual 
nerve and Wharton’s duct, the mylohyoid muscle is 
Figure 5. Topography of video-assised parathyroidectomies 
compared to a four-parathyroid gland exploration
Rycina 5. Topografia paratyroidektomii w asyście wideoskopii 
w porównaniu do eksploracji czterogruczołowej
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identified and retracted medially. Additional dissection 
in the direction of the hyoid bone is performed using 
a rigid cervicoscope. This dissection is passed between 
the submandibular gland and the hyoglossal muscle. 
The hypoglossal nerve lying on the hyoglossal muscle 
is identified and preserved. The hyoid bone is passed 
ventrally in the lateral aspect of the hyoid because the 
thyrohyoid and sternohyoid muscles originate from the 
anterior part of the hyoid bone. This blunt dissection 
is performed carefully because of the proximity of the 
superior laryngeal nerve and its internal branch — the 
internal laryngeal nerve. The thyroid region is entered 
laterally and posterior to the infrahyoid muscles as well 
as the superior pole of the thyroid. The vessels to the 
upper pole of the thyroid are reached by pushing aside 
fibres of the thyrohyoid muscle; these fibres partially 
cover the thyroid lobe. The vessels to the lower pole of 
the thyroid, the inferior thyroid artery, the trachea, and 
the recurrent laryngeal nerve are then visualised. The 
parathyroid glands on one side, posterior to the recur-
rent laryngeal nerve and cranial to the inferior thyroid 
artery (upper parathyroid gland), as well as anterior to 
the recurrent laryngeal nerve and distal to the thyroid 
artery (lower parathyroid gland), respectively, are 
localised and can be resected [29]. The topography of 
this approach is visualised in Figure 6.
RATS (Robot assisted transaxillary surgery) 
A single incision, robot assisted transaxillary surgical 
technique to remove benign endocrine tumours of the 
neck is a feasible option. This technique can be stand-
ardised in properly selected patients. Despite longer 
operating times (> 100 min), very high costs, and the 
high possibility of complications noted (28.5%) in an 
initial series, the excellent three-dimensional visibility 
and the benefit of instrument stability makes RATS an 
interesting addition to the armamentarium of the en-
docrine surgeon. Further study and refinement of RATS 
are warranted prior to its widespread incorporation 
into clinical practice [30]. This technique does not allow 
bilateral exploration.
Surgical procedure
The patient is placed in a supine position on the operat-
ing table. The patient’s ipsilateral arm is positioned so 
that the shoulder is flexed to approximately 160°, and 
internally rotated. After assuring that the patient is 
comfortable, the patient is sedated and intubated with 
general endotracheal anaesthesia.
A 5–6-cm longitudinal incision is made along the 
outer border of the pectoralis major muscle. Skin flaps 
are developed immediately superficial to the pectora-
lis fascia and extended medially and inferiorly to the 
clavicle and sternal notch. 
The robot is positioned over the patient. Three 
robotic tools are secured into the robotic arms and the 
camera is placed at the inferior border of the incision. 
The camera and instruments are deployed under direct 
visualisation. The bedside operating surgeon retracts 
the carotid and internal jugular vessels laterally using 
a laparoscopic bolstered sponge. The assistant surgeon 
maintains a clear field using laparoscopic suction as 
needed. The console surgeon then proceeds to perform 
surgery robotically in a conventional fashion. [30]
Discussion
The aims of any operating techniques (including 
conventional neck exploration) used to treat primary 
hyperparathyroidism are:
 — removal of all hyperfunctioning tissue;
 — preservation of normal tissue (parathyroid glands) 
— to avoid hypoparathyroidism;
 — avoidance of persistent primary hyperparathyroid-
ism;
 — not injuring the recurrent nerve [12];
 — safety for patients and as small as possible risk of 
post-operative complications;
 — good patientcondition after operation.
It has been proven beyond question that minimally 
invasive surgery is performed with low morbidity, 
has good cosmetic results, and results in a small if any 
decrease in the patient’s quality of life. But we must 
remember that the cumulative length of all scars in 
Figure 6. Topography of NOTES approach
Rycina 6. Topografia dostępu NOTES
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the axilla or anterior chest may be longer than in open 
parathyroid surgery. A better cosmetic effect is based on 
a transfer of scars into less visible places. Patients who 
have had endoscopic parathyroidectomies have been 
significantly more satisfied with their scars compared 
to an open approach [31, 32].
Furthermore, some difficulties and complications 
should be remembered when neck surgery by mini-
mally invasive techniques is performed. The first of 
these concerns the removal of parathyroid adenoma 
through a small incision or through an endoscopy 
port or cannula, because it provides a risk for rupture 
of the adenoma, which can lead to parathyromatosis 
[1]. Parathyromatosis is a rare cause of hyperparathy-
roidism. The condition was originally described by 
Palmer et al. in 1975 [35]. About 30 cases have been 
reported in the literature. Type 1 parathyromatosis 
is caused by embryologic development of multiple 
parathyroid glands. Type 2 parathyromatosis, which 
is more common, is a surgical complication associated 
with spillage and seeding of parathyroid tissue during 
parathyroidectomy [36]. The treatment of this rare con-
dition is difficult. Usually repeated neck explorations 
are often unsuccessful. Alcohol ablation and several 
novel calcimimetics have been used in patients with 
unsuccessfully treated parathyromatosis, but experi-
ence is limited [37]. Parathyromatosis can be a problem 
in patients with secondary hyperparathyroidism (with 
chronic renal failure) due to constant stimulation of 
remaining seeded parathyroid tissue after initial par-
athyroidectomy [37, 38]. 
Disruption of parathyroid tissue from its vascular 
supply may lead to transitory hypoparathyroidism. 
Patients after parathyroidectomy should receive oral 
calcium and vitamin D3 immediately after surgery 
(patients with secondary HPT may not have symptoms 
related to hypocalcaemia, unlike patients after parathy-
roidectomy for PHPT). Empirical oral vitamin D3 and 
oral calcium supplementation is usually satisfactory. 
Intravenous calcium is reserved for patients with severe 
symptomatic hypocalcaemia [44, 45]. Symptomatic 
postoperative hypocalcaemia occurs in about 7% of pa-
tients on calcium supplementation. 0.1% of all patients 
require an emergency visit for i.v. calcium. Patients’ 
emergency visits are particularly rare when patients are 
well-educated, receive a supply of calcium supplements 
at discharge, and are managed appropriately. Hand 
‘tingling’ and paresthesia followed by perioral tingling 
and mental fog occur as the most frequent symptoms 
(82% of symptomatic patients). Cramps of the hands 
occur in only 4% of patients with symptoms, and 0.3% 
of all operated patients. The onset of symptoms almost 
always occurs on postoperative day 2 or later. Less than 
0.2% of all operated patients report symptoms of low 
calcium on postoperative day 1. [39] At least during 
the first two weeks, or until serum calcium stabilises, 
serum calcium has to be monitored. Vitamin D supply 
may be reduced to a low dosage but hypocalcaemia, as 
one of the strongest activators in the development of 
SHPT, should be carefully avoided to protect patients 
from recurrent disease [42]. Hungry bone syndrome 
may follow parathyroidectomy [46, 47]. This condi-
tion is marked by extensive hypophosphataemia and 
hypocalcaemia, mostly refractory to oral supplementa-
tion [40–47, 51].
Unilateral exploration-targeted open parathyroidec-
tomy is usually performed under local anaesthesia. The 
quite common disadvantage of this type of anaesthesia 
is neck swelling (oedema), but most patients who expe-
rience such discomfort recover quickly postoperatively 
with complete resolution of symptoms [13]. Another 
difficulty associated with minimally invasive open par-
athyroidectomy is limited visualisation of the operating 
field - only one person at a time can see into the incision. 
As for unilateral exploration, there is one more thing 
which is very important: if the surgeon needs to explore 
both sides of the neck, it is more difficult to convert 
a lateral wound to a standard approach [12]. The most 
common reasons for conversion are: inability to visu-
alise the adenoma, bleeding, and incorrect localisation 
by the sestamibi scans [1].
Problems are associated with endoscopic procedures 
themselves. They are as follows: subcutaneous emphy-
sema (because of long insufflation time), hypercapnia, 
respiratory acidosis, air embolism, inadvertent pneumo-
thorax and tachycardia. There is a 2.2% risk of forming 
a seroma in the area of extensive dissection, even if there 
is a suction drain inserted [33]. Furthermore, an endo-
scopic approach may lead to difficulties in visualisation 
(because of bleeding), some problems connected with 
maintenance of working space, post-operative minimal 
hypesthesia and paresthesia [1]. In addition, endoscopic 
parathyroidectomy can be impractical because of the 
extensive exploration from anterior chest or axilla to 
the neck, and difficulty in identifing contralateral or 
infraclavicular ectopic parathyroid glands [8].
We have to remember that some of the procedures 
discussed above are still experimental or performed 
only in high volume centres as initial trials. Also, the 
costs of some procedures (e.g. RATS, NOTES) limit 
significantly their wider introduction to everyday sur-
gical practice.
Currently, minimally invasive techniques of par-
athyroidectomy are performed with successful out-
comes. In Poland, there have been described only single 
cases of experimental techniques of minimally invasive 
parathyroidectomy and a small series of video-assisted 
parathyroidectomies (n = 15) but preliminary outcomes 
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are very promising. The complication rate is below 3%, 
the success rate is high, and the cosmetic effect is satis-
factory (in subjective patient opinion after six months, 
‘good’ or ‘excellent’ cosmetic effect was achieved in 
90-96%) [52].
Compared to conventional neck exploration,  
mini-invasive techniques provide [1]:
 — decreased pain (because the small wound heals 
quickly),
 — decreased complication rates,
 — shorter hospital stay,
 — shorter duration of surgery (except for endoscopic, 
RATS, NOTES approaches),
 — fast reconstitution,
 — improved cosmetic appearance,
 — cost reduction (as for radio-guided approach),
 — performed with low morbidity with long-term cure 
rate ~97% (whereas traditional neck exploration is 
performed with > 95%).
The surgeon’s experience has a significant influ-
ence on the outcome of parathyroid surgery. Mini-
mally invasive approaches require expertise in the 
anatomy of the neck, parathyroid pathology, and the 
combination of both. Most difficulties can be avoided 
or overcome thanks to the knowledge built on surgi-
cal training and ongoing experience. The learning 
curve is very steep, but it has been proven that the 
length of surgery decreases with surgical experience, 
and may possibly improve with advances in surgical 
instruments [34].
Conclusion
The assessment of morbidities associated with the tech-
niques of unilateral and bilateral exploration for mini-
mally invasive parathyroidectomy has shown benefits 
using either technique. The advantages of minimally 
invasive parathyroidectomy are clear. Performing mini-
mally invasive surgery when possible, and converting 
to conventional neck exploration if necessary, enables 
safe surgery with a minimal risk of complications. Most 
minimally invasive methods are significantly less time-
consuming (in experienced hands) and cosmetically 
attractive. The scars are not necessarily smaller than 
‘classic’ ones in the neck, but they are in an area that is 
covered by clothing. Minimally invasive parathyroid 
surgery (video-assisted, radio-guided and targeted 
open parathyroidectomy) is expected to become the 
gold standard treatment of primary hyperparathy-
roidism. 
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